Roberts Timothy A, Smalley Joshua, Ahrendt Dale
Pediatrics, Children's Mercy Division of Adolescent Medicine, Kansas City, Missouri, USA
Pediatrics, San Antonio Military Medical Center, Fort Sam Houston, Texas, USA.
Br J Sports Med. 2020 Dec 7. doi: 10.1136/bjsports-2020-102329.
To examine the effect of gender affirming hormones on athletic performance among transwomen and transmen.
We reviewed fitness test results and medical records of 29 transmen and 46 transwomen who started gender affirming hormones while in the United States Air Force. We compared pre- and post-hormone fitness test results of the transwomen and transmen with the average performance of all women and men under the age of 30 in the Air Force between 2004 and 2014. We also measured the rate of hormone associated changes in body composition and athletic performance.
Participants were 26.2 years old (SD 5.5). Prior to gender affirming hormones, transwomen performed 31% more push-ups and 15% more sit-ups in 1 min and ran 1.5 miles 21% faster than their female counterparts. After 2 years of taking feminising hormones, the push-up and sit-up differences disappeared but transwomen were still 12% faster. Prior to gender affirming hormones, transmen performed 43% fewer push-ups and ran 1.5 miles 15% slower than their male counterparts. After 1 year of taking masculinising hormones, there was no longer a difference in push-ups or run times, and the number of sit-ups performed in 1 min by transmen exceeded the average performance of their male counterparts.
The 15-31% athletic advantage that transwomen displayed over their female counterparts prior to starting gender affirming hormones declined with feminising therapy. However, transwomen still had a 9% faster mean run speed after the 1 year period of testosterone suppression that is recommended by World Athletics for inclusion in women's events.
研究性别确认激素对跨性别女性和跨性别男性运动表现的影响。
我们回顾了29名跨性别男性和46名跨性别女性在美国空军服役期间开始使用性别确认激素时的体能测试结果和医疗记录。我们将跨性别女性和跨性别男性激素治疗前后的体能测试结果与2004年至2014年期间美国空军所有30岁以下女性和男性的平均表现进行了比较。我们还测量了激素相关的身体成分和运动表现变化率。
参与者的年龄为26.2岁(标准差5.5)。在使用性别确认激素之前,跨性别女性在1分钟内做俯卧撑的次数比同龄女性多31%,做仰卧起坐的次数多15%,跑1.5英里的速度比同龄女性快21%。在服用女性化激素2年后,俯卧撑和仰卧起坐的差异消失,但跨性别女性的跑步速度仍快12%。在使用性别确认激素之前,跨性别男性做俯卧撑的次数比同龄男性少43%,跑1.5英里的速度比同龄男性慢15%。在服用男性化激素1年后,俯卧撑或跑步时间不再有差异,跨性别男性在1分钟内做仰卧起坐的次数超过了同龄男性的平均水平。
跨性别女性在开始使用性别确认激素之前比同龄女性表现出的15%-31%的运动优势随着女性化治疗而下降。然而,在世界田径组织建议的用于女子项目的睾酮抑制1年期之后,跨性别女性的平均跑步速度仍快9%。